A case of severe refractory chronic urticaria: A novel method for evaluation and treatment
Author:
Affiliation:
1. Department of Allergy and Immunology, Wilford Hall Medical Center, Lackland Air Force Base, San Antonio, Texas, USA. hans.otto@lackland.af.mil
Publisher
Oceanside Publications Inc.
Subject
Pulmonary and Respiratory Medicine,General Medicine,Immunology and Allergy
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Chronic-induced urticaria; classification, actual aspects of diagnosis and therapy;Russian Journal of Allergy;2023-04-06
2. Omalizumab for cholinergic urticaria: 6 months prospective study and systematic review of the literature;Dermatologic Therapy;2020-08-11
3. Efficacy and Safety of Omalizumab (Xolair) for Cholinergic Urticaria in Patients Unresponsive to a Double Dose of Antihistamines: A Randomized Mixed Double-Blind and Open-Label Placebo-Controlled Clinical Trial;The Journal of Allergy and Clinical Immunology: In Practice;2019-05
4. Successful treatment of severe cholinergic urticaria with omalizumab: A case report;Journal of Cutaneous Immunology and Allergy;2019-01-16
5. Omalizumab treatment in patients with chronic inducible urticaria: A systematic review of published evidence;Journal of Allergy and Clinical Immunology;2018-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3